close

Enter

Log in using OpenID

Antacid Medications Market - Global Industry Insights 2024.pdf

embed
Antacids are used to treat acid reflux that causes heartburn, indigestion, and stomach upset. They provide quick relief from heartburn, which is a major symptom of gastroesophageal reflux disease and indigestion. Treatment with antacids is symptomat
Artificial Pancreas Market Industry
Antacid Medications Market - Global Industry Insights,
Trends, Outlook, and Opportunity Analysis, 2016–
2024
[DATE]
[COMPANY NAME]
[Company address]
Report Description
Antacid Medications Market Overview
Antacids are used to treat acid reflux that causes heartburn, indigestion, and stomach upset. They
provide quick relief from heartburn, which is a major symptom of gastroesophageal reflux disease and
indigestion. Treatment with antacids is symptomatic and is usually recommended for minor symptoms.
Antacids include magnesium carbonate, aluminum hydroxide, and magnesium trisilicate. Some people
have reported allergic reactions to antacids. Antacids with magnesium may cause diarrhea, while those
containing calcium and aluminum may cause constipation. Long-term use may cause kidney stones and
may increase the risk of contracting osteoporosis. Popular antacid brands include Alka seltzer, Gelusil,
Milk of Magnesia, Maalox, Gaviscon, Mylanta, Rolaids, and Tums.
Distribution channel of Antacids
Antacids are mainly sold through two distribution channels, namely chemists and non-chemist. Nonchemists comprise grocers, general stores, and food stores. Abbott’s Digene and Pfizer’s Gelusil have a
doctor heritage. Eno and Pudin Hara have an ayurvedic base and are available over the counter and are
aiding in growth of the antacid medications market. Over-the-counter availability of antacids have
enabled individuals to self-medicate their bouts of acid reflux, which can increase probability of suffering
from stroke in the future. Antacids are available in different forms such as water dissolving tablet,
powder form, and melt-in-mouth granules.
Get the free sample report @ https://www.coherentmarketinsights.com/insight/requestsample/91
Antacid medications market taxonomy – Formulation, Drug and Demographic
Antacid medications market is classified by various ways such as by formulation, drug and
Demographic. On the basis of formulation, the antacid medications market is classified as tablets,
capsules, suspensions, and drops. On the basis of demographic, antacid medications market is
classified as products for pediatrics and products for adults. On the basis of drug, antacid medications
market is classified as histamine-2 (H2) blockers, proton pump inhibitor, and pro-motility agents.
Examples of H2 blocker include Nizatidine, Ranitidine, Cimetidine, and famotidine. Proton pump
inhibitors used for acid reflux include Rabeprazole, Esomeprazole, Lansoprazole, Pantoprazole, and
Omeprazole. Pro-motility agents stimulate the muscles of gastrointestinal tract and strengthen lower
esophageal sphincter, and reduce reflux into esophagus. Metoclopramide is used to treat heartburn
associated with GERD.
Increasing incidence of acid reflux in North America fueling growth of the antacid medications
market
Increasing trend of self-medication consequently fuels demand for OTC digestive products for treatment
of gastrointestinal distress. Antacids are used to neutralize acidity and thus, are expected to lead to
rampant increase in demand for the same in North America due to rising incidence of gastroesophageal
reflux disease (GERD) in the region. According to a study conducted by American Gastroenterological
Association and published in International Foundation for Functional in February 2016, approximately
one-third of the population in U.S. suffers from GERD. According to a study published in National Center
for Biotechnology Information (NCBI) in June 2014, the range of GERD prevalence was 18.1%–27.8% in
North America, 8.7%–33.1% in the Middle East, 8.8%–25.9% in Europe, 2.5%–7.8% in East Asia, and
11.6% in Australia. Increasing prevalence of GERD creates a favorable environment growth of the
antacid medications market.
View the full research report @ https://www.coherentmarketinsights.com/ongoinginsight/antacid-medications-market-91
Increasing self-medication trend driving antacid medications market growth
Increasing inclination of the populace towards self-medication supplemented by growing availability of
over-the-counter products in convenient to use sachets is a prevalent trend observed in the market. This
trend is expected to continue over the forecast period, in turn fueling market growth.
Global players operating in the antacid medications market
Various companies manufacture antacids and other products for indigestion. Some of these are
GlaxoSmithKline plc, Dabur India Limited, Abbott Laboratories, and Pfizer, Inc. Sun Pharma launched
an ayurvedic digestive remedy called Pepmelt to compete with popular antacids such as Eno (GSK
consumer healthcare), Digene (Abbott India), Pudin Hara (Dabur), and Gelusil (Pfizer). According to
2014 estimates of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),
approximately 20% of the U.S. population suffered from gastroesophageal reflux disease, or GERD.
About Us
COMPANY OVERVIEW
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting
our plethora of clients achieve transformational growth by helping them make critical business decisions.
We are headquartered in India, having office at global financial capital in the U.S. Our client base includes
players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to
help businesses around the globe deliver practical and lasting results through various recommendations
about operational improvements, technologies, emerging market trends and new working methods. We
offer both customized and syndicated market research reports that help our clients create visionary growth
plans to provide traction to their business. We meticulously study emerging trends across various
industries at both the global and regional levels to identify new opportunities for our clientele. Our global
team of over 100 research analysts and freelance consultants provide market intelligence from the very
molecular country level and also provide a global perspective of the market. Our team is of the most vital
cog in our robust machinery that gives us the ability to deliver independent insight relying on our cognitive
defusion training module.This allows for an objective and unbiased assessment of the market. We pride
ourselves in my constantly striving to update our extremely in-depth understanding of the market by
closely monitoring and analyzing markets, trends, and emerging best practices, across allfathomable
industries under the sun. This enables us to equip our valued clientele with key decisive inputs to capitalize
on lucrative growth opportunities in the market and to follow firmly position themselves on a high growth
path in the future.
Contact Us
CORPORATE OFFICE:
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel No: (+1)206-701-6702
[email protected]
Visit Blog: http://healthcaremarketconsulting.blogspot.in/
1/--pages
Report inappropriate content